Lab Information
Évelyne Vinet (MD/PhD)
ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
Systemic lupus erythematosus • rheumatoid arthritis • female reproductive health • epidemiology • pregnancy and rheumatic diseases • administrative databases • perinatal outcomesResearch Interests
The primary goal of my research program is to use epidemiologic methods to improve reproductive health outcomes in women with rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and their offspring. To this end, I have created the world's largest cohort of offspring from SLE women, which has driven our novel findings demonstrating that SLE offspring are at increased risk of autism spectrum disorders, congenital heart defects, and stillbirths. I am also actively spear-heading research initiatives to elucidate how therapies used to treat rheumatic diseases (e.g. TNF-inhibitors and other biologics) impact health outcomes in these patients and their offspring.Research areas: Clinical Epidemiology; Rheumatic Diseases; Non-Communicable Disease Epidemiology; Pharmacoepidemiology; Population and Public Health
Team Members
| Name | Position |
|---|
Latest Publications
- Lee, J.-E., Mendel, A., Malhamé, I., Barber, M. R. W., Clarke, A. E., Fortin, P. R., Hanly, J. G., Legge, A., Peschken, C., Laskin, C. A., Touma, Z., Urowitz, M. B., Bernatsky, S. & Vinet, É. (2025). An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial. Rheumatology (Oxford, England).
- Flatman, L. K., Bernatsky, S., Bérard, A. & Vinet, É. (2025). Patterns of Use and Discontinuation for Tumour Necrosis Factor Inhibitors in Pregnant Women: Insights from a Real-World Sample. The Journal of rheumatology.
- Krustev, E., Fritzler, M. J., Bernatsky, S., St Pierre, Y., Sciore, P. J., Vinet, E., Pineau, C. A., Mendel, A., Kalache, F., Grenier, L.-P., Cotton, T., Niaki, O. Z. & Choi, M. Y. (2025). Anti-myxovirus resistance protein 1: a novel biomarker for autoimmune myositis and interstitial lung disease in systemic lupus erythematosus. Annals of the rheumatic diseases, vol. 84, p. 881-882.
- Stanciu, M., Lee, J.-E., McDonald, E. G., Clark, G., Pineau, C. A., Kalache, F., Grenier, L.-P., Vinet, É., Bernatsky, S. & Mendel, A. (2025). Medication-related hospitalisations in patients with SLE. Lupus science & medicine, vol. 12.
- Mainbourg, S., Sheehy, O., Gorgui, J., Vinet, E. & Bérard, A. (2024). Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study. BMC pregnancy and childbirth, vol. 24, p. 765.
- Mendel, A. & Vinet, É. (2024). Connecting the Docs in Vasculitis Pregnancies. The Journal of rheumatology, vol. 51, p. 949-952.
- Mendel, A., Behlouli, H., Vinet, É., Curtis, J. R. & Bernatsky, S. (2025). Trimethoprim sulfamethoxazole prophylaxis and serious infections in granulomatosis with polyangiitis treated with rituximab. Rheumatology (Oxford, England), vol. 64, p. 2041-2049.
- Flatman, L. K., Malhamé, I., Colmegna, I., Bérard, A., Bernatsky, S. & Vinet, É. (2024). Tumour necrosis factor inhibitors and serious infections in reproductive-age women and their offspring: a narrative review. Scandinavian journal of rheumatology, p. 1-12.
- Schreiber, K., Giles, I., Costedoat-Chalumeau, N., Nelson-Piercy, C., Dolhain, R. J., Mosca, M., Förger, F., Fischer-Betz, R., Molto, A., Tincani, A., Pasquier, E., Marin, B., Elefant, E., Salmon, J., Bermas, B. L., Sammaritano, L., Clowse, M. E. B., Chambers, C., Buyon, J., Inoue, S. A., Agmon-Levin, N., Aguilera, S., Emadi, S. A., Andersen, J., Andrade, D., Antovic, A., Arnaud, L., Christiansen, A. A., Avcin, T., Badreh-Wirström, S., Bertsias, G., Bini, I., Bobirca, A., Branch, W., Brucato, A., Bultink, I., Capela, S., Cecchi, I., Cervera, R., Chighizola, C., Cobilinschi, C., Cuadrado, M. J., Dey, D., Etomi, O., Espinosa, G., Flint, J., Fonseca, J.-E., Fritsch-Stork, R., Gerosa, M., Glintborg, B., Skorpen, C. G., Goulden, B., Graversgaard, C., Gunnarsson, I., Gupta, L., Hetland, M., Hodson, K., Hunt, B. J., Isenberg, D., Jacobsen, S., Khamashta, M., Levy, R., Linde, L., Lykke, J., Meissner, Y., Moore, L., Morand, E., Navarra, S., Opris-Belinski, D., Østensen, M., Ozawa, H., Perez-Garcia, L. F., Petri, M., Pons-Estel, G. J., Radin, M., Raio, L., Rottenstreich, A., Ruiz-Irastorza, G., Tunjić, S. R., Rygg, M., Sciascia, S., Strangfeld, A., Svenungsson, E., Tektonidou, M., Troldborg, A., Vinet, E., Vojinovic, J., Voss, A., Wallenius, M. & Andreoli, L. (2023). Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases. The Lancet. Rheumatology, vol. 5, p. e501-e506.
- Smith, N. A. & Vinet, É. (2024). Ambulatory Fetal Heart Monitoring: the New Kid on the Block?. Arthritis & rheumatology (Hoboken, N.J.), vol. 76, p. 345-347.
See also
